Vimarsana
Biggest News Aggregation in the World

Page 4 - Michael Melgar News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael Melgar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Melgar Today - Breaking & Trending Today

RSV Vaccine Approved For Older Adults By FDA - Vimarsana News

RSV Vaccine Approved For Older Adults By FDA

(CTN News) - Wednesday, the FDA approved the RSV vaccine from drugmaker GSK to protect seniors against the virus that causes.........

FDA Says Guillain-Barre Syndrome Is Possible Risk of Pfizer's RSV Vaccine for Older Adults - Vimarsana News

FDA Says Guillain-Barre Syndrome Is Possible Risk of Pfizer's RSV Vaccine for Older Adults

The FDA sees a potential risk and has asked Pfizer to conduct a safety study on Guillain-Barre after a potential approval, which the company said it would do.

FDA Says Guillain-Barre Syndrome Is Possible Risk of Pfizer's RSV Vaccine for Older Adults - Vimarsana News

FDA Says Guillain-Barre Syndrome Is Possible Risk of Pfizer's RSV Vaccine for Older Adults

The FDA sees a potential risk and has asked Pfizer to conduct a safety study on Guillain-Barre after a potential approval, which the company said it would do.

New Surveillance Case Definition Developed for MIS-C - Vimarsana News

New Surveillance Case Definition Developed for MIS-C

MONDAY, Dec. 19, 2022 (HealthDay News) -- A new surveillance case definition for multisystem inflammatory syndrome in children (MIS-C) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has

Source: vtcng.com
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance — One Hospital, California, July 15–September 23, 2021, and December 21, 2021–January 27, 2022 - Vimarsana News

Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance — One Hospital, California, July 15–September 23, 2021, and December 21, 2021–January 27, 2022

This report describes how COVID-19 vaccinations and booster doses were associated with lower chances of ICU admission for hospitalized SARS-CoV-2 infected adults during Omicron predominance.

Source: cdc.gov